Ingenol Mebutate Prior to Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis: Results of a Pilot Study

Abstract

Keywords

actinic keratosis ingenol mebutate methyl-aminolevulinate photodynamic therapy pilot study

Get full access to this article

View all access options for this article.

References

Jansen

MHE.

Kessels

JPHM.

Nelemans

et al. Randomized trial of four treatment approaches for actinic keratosis. N Engl J Med. 2019;380(10):935-946.doi:10.1056/NEJMoa1811850

30855743

de Berker

McGregor

JM.

Mohd Mustapa

MF.

Exton

LS.

Hughes

. British association of dermatologists’ guidelines for the care of patients with actinic keratosis 2017. Br J Dermatol. 2017;176(1):20-43.doi:10.1111/bjd.15107

28098380

Poulin

Lynde

CW.

Barber

et al. Non-Melanoma skin cancer in Canada chapter 3: management of actinic keratoses. J Cutan Med Surg. 2015;19(3):227-238.doi:10.1177/1203475415583414

25926621

Heppt

MV.

Steeb

Leiter

Berking

. Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(5):863-873.doi:10.1111/jdv.15459

30710390

Tanaka

Ohata

Ishii

et al. Comparative study for the effect of photodynamic therapy, imiquimod immunotherapy and combination of both therapies on 40 lesions of actinic keratosis in Japanese patients. J Dermatol. 2013;40(12):962-967.doi:10.1111/1346-8138.12310

24147543